{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:33:30Z","timestamp":1788449610105,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1007\/s11864-001-0073-x","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T18:23:48Z","timestamp":1184610228000},"page":"517-527","source":"Crossref","is-referenced-by-count":27,"title":["Neoplastic meningitis"],"prefix":"10.1007","volume":"2","author":[{"given":"Lyndon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Glantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"73_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982, 49:759\u2013772. Classic clinical and laboratory description of this disease; still the best overview of solid tumor neoplastic meningitis available.","journal-title":"Cancer"},{"key":"73_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/1097-0142(197807)42:1<283::AID-CNCR2820420142>3.0.CO;2-#","volume":"42","author":"HY Yap","year":"1978","unstructured":"Yap HY, Yap BS, Tashima CK, et al.: Meningeal carcinomatosis in breast cancer. Cancer 1978, 42:283\u2013286.","journal-title":"Cancer"},{"key":"73_CR3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archneur.1997.00550130008003","volume":"54","author":"MC Chamberlain","year":"1997","unstructured":"Chamberlain MC: Carcinomatous meningitis. Arch Neurol 1997, 54:16\u201317.","journal-title":"Arch Neurol"},{"key":"73_CR4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/oxfordjournals.annonc.a010755","volume":"7","author":"GC Jayson","year":"1996","unstructured":"Jayson GC, Howell A: Carcinomatous meningitis in solid tumors. Ann Oncol 1996, 7:773\u2013786.","journal-title":"Ann Oncol"},{"key":"73_CR5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","volume":"53","author":"M Balm","year":"1996","unstructured":"Balm M, Hammock J: Leptomeningeal carcinomatosis. Arch Neurol 1996, 53:626\u2013632.","journal-title":"Arch Neurol"},{"key":"73_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"SA Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ: Leptomeningeal carcinomatosis. Cancer Treat Rev 1999, 25:103\u2013119. Extremely thoughtful, up-to-date, detailed, and meticulously referenced general review article.","journal-title":"Cancer Treat Rev"},{"key":"73_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1023\/A:1005956925637","volume":"38","author":"LM DeAngelis","year":"1998","unstructured":"DeAngelis LM: Current diagnosis and treatment of leptomeningeal metastases. J Neurooncol 1998, 38:245\u2013252.","journal-title":"J Neurooncol"},{"key":"73_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","volume":"51","author":"RJ Greenlee","year":"2001","unstructured":"Greenlee RJ, Hill-Harmon MB, Murry J, Thun M: Cancer Statistics 2001. CA Cancer J Clin 2001, 51:15\u201336.","journal-title":"CA Cancer J Clin"},{"key":"73_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02341153","volume":"9","author":"JG Kaplan","year":"1990","unstructured":"Kaplan JG, DeSouza TG, Farkash A, et al.: Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas, and leukemias. J Neurooncol 1990, 9:225\u2013229.","journal-title":"J Neurooncol"},{"key":"73_CR10","first-page":"143","volume-title":"Neurologic Complications of Cancer","author":"JB Posner","year":"1995","unstructured":"Posner JB: Neurologic Complications of Cancer. Philadelphia: F.A. Davis 1995:143\u2013171."},{"key":"73_CR11","first-page":"733","volume":"61","author":"WR Shapiro","year":"1977","unstructured":"Shapiro WR, Posner JB, Ushio Y, et al.: Treatment of meningeal neoplasms. Cancer Treat Rep 1977, 61:733\u2013743.","journal-title":"Cancer Treat Rep"},{"key":"73_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0277-5379(87)90410-X","volume":"23","author":"MG Malkin","year":"1987","unstructured":"Malkin MG, Posner JB: Cerebrospinal fluid tumor markers for the diagnosis and management of leptomeningeal metastases. Eur J Cancer Clin Oncol 1987, 23:1\u20134.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"73_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0002-9343(81)90254-0","volume":"71","author":"RS Aroney","year":"1981","unstructured":"Aroney RS, Dalley DN, Chan WK, et al.: Meningeal carcinomatosis in small cell carcinoma of the lung. Am J Med 1981, 71:26\u201332.","journal-title":"Am J Med"},{"key":"73_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(19950715)76:2<232::AID-CNCR2820760212>3.0.CO;2-0","volume":"76","author":"RJ Freilich","year":"1995","unstructured":"Freilich RJ, Seidman AD, DeAngelis LM: Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer 1995, 76:232\u2013236.","journal-title":"Cancer"},{"key":"73_CR15","first-page":"7","volume-title":"Cerebrospinal fluid in diseases of the nervous system","author":"RA Fishman","year":"1992","unstructured":"Fishman RA: Cerebrospinal fluid in diseases of the nervous system, edn. 2. Philadelphia: W.B. Saunders; 1992:7\u201340. The ultimate reference for any detail regarding the cerebrospinal fluid; justly renowned.","edition":"edn. 2"},{"key":"73_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1023\/A:1005723801479","volume":"32","author":"LK Norris","year":"1997","unstructured":"Norris LK, Grossman SA, Olivi A: Neoplastic meningitis following surgical resection of isolated cerebellar metastases: a potentially preventable complication. J Neurooncol 1997, 32:215\u2013223.","journal-title":"J Neurooncol"},{"key":"73_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0002-9343(82)90404-1","volume":"73","author":"SA Grossman","year":"1982","unstructured":"Grossman SA, Trump DL, Chen DCP, et al.: Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis: an evaluation using 111indium DTPA ventriculography. Am J Med 1982, 73:641\u2013647.","journal-title":"Am J Med"},{"key":"73_CR18","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.41.11.1765","volume":"41","author":"MC Chamberlain","year":"1991","unstructured":"Chamberlain MC, Corey-Bloom J: Leptomeningeal metastases: 111indium DTPA CSF flow studies. Neurol 1991, 41:1765\u20131769.","journal-title":"Neurol"},{"key":"73_CR19","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1002\/1097-0142(19950615)75:12<2919::AID-CNCR2820751220>3.0.CO;2-9","volume":"75","author":"MJ Glantz","year":"1995","unstructured":"Glantz MJ, Hall WA, Cole BF, et al.: Diagnosis, management of, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer 1995, 75:2919\u20132931. Review of the technique, results, and clinical importance of assessing CSF flow; abundant illustrations of CSF flow studies that reflect normal and abnormal results.","journal-title":"Cancer"},{"key":"73_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s004320000158","volume":"127","author":"U Roelcke","year":"2001","unstructured":"Roelcke U, Leenders KL: PET in neuro-oncology. J Cancer Res Clin Oncol 2001, 127:2\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"key":"73_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","volume":"82","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Glantz LK, et al.: Cerebrospinal fluid cytology in patients with cancer: how to minimize false negative results. Cancer 1998, 82:733\u2013739. Clinical study and review that describes the optimum techniques (volume, site, processing, number of samplings) for evaluating CSF cytology.","journal-title":"Cancer"},{"key":"73_CR22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","volume":"11","author":"SA Grossman","year":"1993","unstructured":"Grossman SA, Finkelstein DM, Ruckdeschchel JC, et al.: Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 1993, 11:561\u2013569. One of only four randomized clinical trials in this disease. This well-written work contains valuable information on the disease and treatment.","journal-title":"J Clin Oncol"},{"key":"73_CR23","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","volume":"5","author":"RN Hitchins","year":"1987","unstructured":"Hitchins RN, Bell DR, Woods RL, Levi JA: A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J. Clin. Oncol 1987, 5:1655\u20131662. One of only four randomized clinical trials in this disease. Contains important clinical information.","journal-title":"J. Clin. Oncol"},{"key":"73_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/foc.1998.4.6.7","volume":"4","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Chamberlain MC, Walters BC: Diagnosis and outcome measures in trials for neoplastic meningitis: a review of the literature and clinical experience. Neurosurg Focus 1998, 4:1\u20137.","journal-title":"Neurosurg Focus"},{"key":"73_CR25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.50.4.1173","volume":"50","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC: Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers. Neurology 1998, 50:1173\u20131175. Excellent, concise, recent clinical series and review of the role of biochemical markers in the diagnosis of neoplastic meningitis.","journal-title":"Neurology"},{"key":"73_CR26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ana.410080609","volume":"8","author":"SC Schold","year":"1980","unstructured":"Schold SC, Wasserstrom WR, Fleisher M, et al.: Cerebrospinal fluid biochemical markers of central nervous system metastases. Ann Neurol 1980, 8:597\u2013604.","journal-title":"Ann Neurol"},{"key":"73_CR27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.54.8.1670","volume":"54","author":"G Stockhammer","year":"2000","unstructured":"Stockhammer G, Poewve W, Burgstaller S, et al.: Vascular endothelial growth factor in CSF. A biological marker of carcinomatous meningitis. Neurology 2000, 54:1670\u20131676.","journal-title":"Neurology"},{"key":"73_CR28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/jnnp.54.2.119","volume":"54","author":"AP van Zanten","year":"1991","unstructured":"van Zanten AP, Twijnstra A, Ongerboer de Visser BW, et al.: Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy. J Neurol Neurosurg Psychiatry 1991, 54:119\u2013123.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"73_CR29","first-page":"151","volume-title":"Handbook of Clinical Neurology.","author":"MC Chamberlain","year":"1997","unstructured":"Chamberlain MC: Leptomeningeal metastases. In Handbook of Clinical Neurology. Edited by Vecht CHJ. Amsterdam, the Netherlands: Elsevier Science BV; 1997:25:151\u2013165."},{"key":"73_CR30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00005072-199205000-00001","volume":"51","author":"SH Bigner","year":"1992","unstructured":"Bigner SH: Cerebrospinal fluid (CSF) cytology: current status and diagnostic applications. J Neuropathol Exp Neurol 1992, 51:235\u2013245.","journal-title":"J Neuropathol Exp Neurol"},{"key":"73_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4","volume":"77","author":"CH Rhodes","year":"1996","unstructured":"Rhodes CH, Glantz MJ, Glantz L, et al.: A comparison of PCR examination of CSF and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 1996, 77:543\u2013548.","journal-title":"Cancer"},{"key":"73_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<923::AID-CNCR18>3.0.CO;2-2","volume":"82","author":"MH Friedberg","year":"1998","unstructured":"Friedberg MH, Glantz MJ, Klempner MS, et al.: Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases and carcinomatous meningitis. Cancer 1998, 82:923\u2013930.","journal-title":"Cancer"},{"key":"73_CR33","first-page":"165a","volume":"19","author":"L Kim","year":"2000","unstructured":"Kim L, Glantz MJ, Callanan H, et al.: Diagnostic utility and potential therapeutic applications of inter-alpha trypsin inhibitor (ITI) in the cerebrospinal fluid of patients with primary and metastatic central nervous system cancer [abstract]. Pro Am Soc Clin Oncol 2000, 19:165a.","journal-title":"Pro Am Soc Clin Oncol"},{"key":"73_CR34","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/1097-0142(20010815)92:4<856::AID-CNCR1393>3.0.CO;2-9","volume":"92","author":"N Katopodis","year":"2001","unstructured":"Katopodis N, Glantz M, Kim L, et al.: Lipid associated sialoprotien in the cerebrospinal fluid: association with brain malignancies. Cancer 2001, 92:856\u2013862.","journal-title":"Cancer"},{"key":"73_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ana.410380111","volume":"38","author":"RJ Freilich","year":"1995","unstructured":"Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995, 38:51\u201357.","journal-title":"Ann Neurol"},{"key":"73_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s004150050459","volume":"246","author":"CS Straathof","year":"1999","unstructured":"Straathof CS, de Bruin HG, Dippel DW, Vecht CJ: The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 1999, 246:810\u2013814.","journal-title":"J Neurol"},{"key":"73_CR37","first-page":"144","volume":"13","author":"SA Grossman","year":"1999","unstructured":"Grossman SA, Spence A: Management of leptomeningeal metastases: National Comprehensive Cancer Network guidelines. Oncology 1999, 13:144\u2013152. Superb review and treatment algorithm for neoplastic meningitis.","journal-title":"Oncology"},{"key":"73_CR38","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA, et al.: A randomized trial of a slow-release formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999, 17:3110\u20133116. One of only four randomized clinical trials regarding this disease that focuses on lymphomatous meiningitis only.","journal-title":"J Clin Oncol"},{"key":"73_CR39","first-page":"3394","volume":"5","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, Jaeckle KA, Chamberlain MC, et al.: A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 1999, 5:3394\u20133402. The most recent of only four randomized clinical trials regarding this disease; useful information regarding risk factors, treatment, and outcomes is provided.","journal-title":"Clin Cancer Res"},{"key":"73_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF02147089","volume":"7","author":"SA Grossman","year":"1989","unstructured":"Grossman SA, Reinhard CS, Loats HL: The intracerebral penetration of intraventricularly administered methotrexate: a quantitative autoradiographic study. J Neurooncol 1989, 7:319\u2013328.","journal-title":"J Neurooncol"},{"key":"73_CR41","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/jnci\/80.15.1211","volume":"5","author":"PA Burch","year":"1988","unstructured":"Burch PA, Grossman SA, Reinhard CS: Spinal cord penetration of intrathecally administered cytarabine and methotrexate: a quantitative autoradiographic study. J Natl Cancer Inst 1988, 5:1211\u20131216.","journal-title":"J Natl Cancer Inst"},{"key":"73_CR42","first-page":"555","volume":"12","author":"SM Larson","year":"1971","unstructured":"Larson SM, Shcall Gl, Di Chiro G: The influence of previous lumbar puncture and pneumoencephalography on the incidence of unsuccessful radioisotope cisternography. J Nucl Med 1971, 12:555\u2013557.","journal-title":"J Nucl Med"},{"key":"73_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJM197507242930402","volume":"293","author":"WR Shapiro","year":"1975","unstructured":"Shapiro WR, Young DF, Metha BM: Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975, 293:161\u2013166.","journal-title":"N Engl J Med"},{"key":"73_CR44","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.44.8.1463","volume":"44","author":"T Siegal","year":"1994","unstructured":"Siegal T, Lossos A, Pfeffer MR: Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology 1994, 44:1463\u20131469.","journal-title":"Neurology"},{"key":"73_CR45","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1200\/JCO.1993.11.11.2186","volume":"11","author":"S Kim","year":"1993","unstructured":"Kim S, Chatelut E, Kim JC, et al.: Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol 1993, 11:2186\u20132193.","journal-title":"J Clin Oncol"},{"key":"73_CR46","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","volume":"16","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Recht L, et al.: High dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary? J Clin Oncol 1998, 16:1561\u20131567.","journal-title":"J Clin Oncol"},{"key":"73_CR47","first-page":"3","volume":"56","author":"MC Chamberlain","year":"2001","unstructured":"Chamberlain MC: A phase 2 trial of intra-CSF alpha interferon in the treatment of neoplastic meningitis. abstract AAN 2001, 56:(suppl):3:A476 S64.002.","journal-title":"Cancer"},{"issue":"suppl","key":"73_CR48","first-page":"3","volume":"56:","author":"H Schulz","year":"2001","unstructured":"Schulz H, Pels H, Rehwald U, et al.: Treatment of a relapsed radio- and chemotherapy refractory primary CNS lymphoma with the anti-CD-20 antibody IDECC2B8 abstract AAN 2001, 56:(suppl):3:A411 P06.030.","journal-title":"Cancer"},{"key":"73_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1023\/A:1005996606073","volume":"38","author":"HB Coakham","year":"1998","unstructured":"Coakham HB, Kemshead JT: Treatment of neoplastic meningitis by targeted radiation using (131)I-radiolabelled monoclonal antibodies. Results of responses and long term follow-up in 40 patients. J Neurooncol 1998, 38:225\u2013232.","journal-title":"J Neurooncol"},{"key":"73_CR50","first-page":"963","volume":"2","author":"MT Brown","year":"1996","unstructured":"Brown MT, Coleman RE, Friedman AH, et al.: Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results. Clin Cancer Res 1996, 2:963\u2013972.","journal-title":"Clin Cancer Res"},{"key":"73_CR51","first-page":"2105","volume":"66","author":"BA Kamen","year":"1982","unstructured":"Kamen BA, Holcenberg JS, Sieger SE: AziridinylbenzoquinoneAZQ) treatment of central nervous system leukemia: Letter to the editor. Cancer Treat Rep 1982, 66:2105\u20132106.","journal-title":"Cancer Treat Rep"},{"key":"73_CR52","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/jnci\/84.15.1203","volume":"84","author":"MA Champagne","year":"1992","unstructured":"Champagne MA, Sislver HKB: Intrathecal dacarbazine treatment of leptomeningeal malignant melanoma. J Natl Cancer Inst 1992, 84:1203\u20131204.","journal-title":"J Natl Cancer Inst"},{"key":"73_CR53","first-page":"626","volume":"13","author":"T Huang","year":"1997","unstructured":"Huang T, Howng SL: Intrathecal ACNU against experimental leptomeningeal tumors. Kaosiung J Med Sci 1997, 13:626\u2013630.","journal-title":"Kaosiung J Med Sci"},{"key":"73_CR54","first-page":"169","volume":"46","author":"FM Balis","year":"1986","unstructured":"Balis FM, Lester C, Poplack DG: Pharmacokinetics of trimetrexate (NSC 352122) in monkeys. Cancer Res 1986, 46:169\u2013174.","journal-title":"Cancer Res"},{"key":"73_CR55","first-page":"4710","volume":"54","author":"HS Friedman","year":"1994","unstructured":"Friedman HS, Archer GE, Mc Lendon Re, et al.: Intrathecal melphalan therapy of human neoplastic meningitis in athymic nude rats. Cancer Res 1994, 54:4710\u20134714.","journal-title":"Cancer Res"},{"key":"73_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF01053277","volume":"19","author":"M Kochi","year":"1994","unstructured":"Kochi M, Kuratsu J, Mihara Y, et al.: Neurotoxicity and pharmacokinetics of ventricularlumbar perfusion of methyl -6[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs. J neurooncol 1994, 19:239\u2013244.","journal-title":"J neurooncol"},{"key":"73_CR57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00689195","volume":"36","author":"S Blaney","year":"1995","unstructured":"Blaney S, Cole D, Godwin K, et al.: Intrathecal administration of topotecan in nonhuman primates. Cancer Chemother Pharmacol 1995, 36:121\u2013124.","journal-title":"Cancer Chemother Pharmacol"},{"key":"73_CR58","first-page":"57a","volume":"20","author":"HS Friedman","year":"2001","unstructured":"Friedman HS, Petros W, Rich JN, et al.: Phase I trial of intrathecal Spartaject busulfan for patients with neoplastic meningitis [abstract]. Proc Am Soc Clin Oncol 2001, 20:57a.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"73_CR59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00179434","volume":"3","author":"U Bruntsch","year":"1985","unstructured":"Bruntsch U, Groos G, Hiller TA, et al.: Phase I study of mafosfamide-cyclohexlyamine (ASTA-Z-7557, NSC 345842) and limited Phase-I data on mafosfamidelysine. Invest New Drugs 1985, 3:293\u2013296.","journal-title":"Invest New Drugs"},{"key":"73_CR60","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1200\/JCO.1989.7.11.1701","volume":"7","author":"MS Mitchell","year":"1989","unstructured":"Mitchell MS: Relapse in the central nervous system in melanoma patients successfully treated with biomodulators. J Clin Oncol 1989, 7:1701\u20131709.","journal-title":"J Clin Oncol"},{"key":"73_CR61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00002371-199301000-00007","volume":"13","author":"WE Samlowski","year":"1993","unstructured":"Samlowski WE, Park KJ, Galinski RE, et al.: Intrathecal administration of interleukin-2 for meningeal carcinomatosis due to malignant melanoma: Sequential evaluation of intracranial pressure, cerebrospinal fluid cytology and cytokine induction. J Immunother 1993, 13:49\u201354.","journal-title":"J Immunother"},{"key":"73_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00253514","volume":"9","author":"H Doge","year":"1984","unstructured":"Doge H, Hiscs R: Intrathecal therapy with 198Au-Colloid for meningosis prophylaxis. Eur J Nucl Med 1984, 9:125\u2013128.","journal-title":"Eur J Nucl Med"},{"key":"73_CR63","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3171\/jns.1996.85.4.0648","volume":"85","author":"AJ Vincent","year":"1996","unstructured":"Vincent AJ, Esandi MD, van Someran G, et al.: Treatment of leptomeningeal metastases in a rat model using a recombinant adenovirus containing the HSV-tk gene. J Neurosurg 1996, 85:648\u2013654.","journal-title":"J Neurosurg"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0073-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-001-0073-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0073-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0073-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T19:32:02Z","timestamp":1652643122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-001-0073-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["73"],"URL":"https:\/\/doi.org\/10.1007\/s11864-001-0073-x","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}